All news articles for November 2019

(Image: Getty/Radachynskyi)

Recro spins out Baudax to boost CDMO focus

By Vassia Barba

Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.

(Image: Getty/chombosan)

FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE

The danger of ‘going too far’ with AI

By Vassia Barba

Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.

(Image: Getty/NatalyaBurova)

CPhI Worldwide 2019

'E-label' packaging to improve patient experience

By Vassia Barba

Sharp’s electronic label for drug packaging can be updated again and again, saving time and costs whilst also improving patient engagement during clinical trials.

(Image: Getty/DenKuvaiev)

The next act: ACRO, R&D Caucus moving forward with second Cures bill

By Melissa Fassbender

ACRO is collaborating with the Congressional Research and Development Caucus and others to bring forth a new Cures bill focused, in part, on patient engagement, data, and digital health – with draft legislation anticipated early next year.